Harvard Bioscience Ownership | Who Owns Harvard Bioscience?

Overview Forecast RevenueFinancials Chart Transcripts

Harvard Bioscience Ownership Summary

Harvard Bioscience is owned by 37.45% institutional investors, 10.30% insiders, and 52.24% retail investors. Amh equity is the largest institutional shareholder, holding 9.14% of HBIO shares. Harvey Partners Small-Cap Opportunity is the top mutual fund, with 4.42% of its assets in Harvard Bioscience shares.

HBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Harvard Bioscience	37.45%	10.30%	52.24%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Medical Instruments & Supplies Stocks	40.77%	13.85%	45.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Amh equity	4.05M	9.14%	$1.77M
Blackrock	2.84M	6.55%	$8.10M
Harvey partners	2.05M	4.63%	$898.92K
Vanguard group	1.85M	4.18%	$812.96K
Acadian asset management	1.07M	2.41%	$467.00K
Meros investment management, lp	918.26K	2.07%	$402.70K
Renaissance	868.48K	1.96%	$380.83K
Blackrock funding, inc. /de	621.37K	1.40%	$272.47K
Granahan investment management	603.52K	1.36%	$264.64K
Dimensional fund advisors lp	496.14K	1.12%	$217.56K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Amh equity	4.05M	2.21%	$1.77M
Meros investment management, lp	918.26K	0.17%	$402.70K
Acuitas investments	491.09K	0.14%	$215.34K
Williams & novak	275.50K	0.09%	$120.81K
Harvey partners	2.05M	0.08%	$898.92K
Clarivest asset management	114.27K	0.03%	$325.67K
Triton wealth management, p	13.41K	0.03%	$44.26K
Pasadena private wealth	243.91K	0.02%	$106.95K
Granahan investment management	603.52K	0.01%	$264.64K
Abel hall	37.33K	0.01%	$16.57K

Top Buyers

Holder	Shares	% Assets	Change
Amh equity	4.05M	2.21%	538.83K
Two sigma investments, lp	474.16K	0.00%	276.37K
Two sigma advisers, lp	243.16K	0.00%	196.31K
Williams & novak	275.50K	0.09%	168.93K
Assenagon asset management	139.22K	0.00%	102.42K

Top Sellers

Holder	Shares	% Assets	Change
Royce & associates lp	-	-	-1.78M
B. riley asset management	-	-	-1.35M
Boothbay fund management	-	-	-1.15M
Heartland advisors	-	-	-1.11M
Granahan investment management	603.52K	0.01%	-897.99K

New Positions

Holder	Shares	% Assets	Change	Value
Corsair capital management	100.00K	0.01%	100.00K	$43.85K
Abel hall	37.33K	0.01%	37.33K	$16.57K
Susquehanna group, llp	35.46K	-	35.46K	$74.81K
Cubist systematic strategies	14.14K	0.00%	14.14K	$40.31K
Northwestern mutual wealth management	1.90K	-	1.90K	$833.00

Sold Out

Holder	Change
Ifp advisors	-15.00
Capital performance advisors llp	-41.00
True wealth design	-56.00
Ronald blue trust	-78.00
Smartleaf asset management	-174.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	58	-6.45%	16,593,159	-10.92%	37	2.12%	18	-41.94%	24	-
Jun 30, 2025	65	-27.78%	18,909,639	-26.25%	42	1.26%	33	10.00%	25	-34.21%
Mar 31, 2025	2	-97.89%	3,715,394	-87.95%	8	0.17%	-	-100.00%	2	-91.67%
Dec 31, 2024	45	-52.63%	15,332,661	-50.99%	35	0.68%	26	-42.22%	8	-70.37%
Sep 30, 2024	95	-5.94%	30,343,546	-4.61%	69	1.30%	45	-26.23%	28	7.69%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Harvey Partners Small-Cap Opportunity	1.97M	4.42%	-52.56K
Vanguard US Total Market Shares ETF	1.26M	2.86%	-
Vanguard Total Stock Mkt Idx Inv	1.23M	2.77%	-26.99K
Heartland Value Investor	937.14K	2.12%	-171.43K
Royce Micro-Cap Trust Inc	860.63K	1.95%	-11.42K
Royce Micro Cap Trust	860.63K	1.95%	-11.42K
Acuitas US Microcap Strategy	682.85K	1.57%	-
Royce Micro-Cap Invmt	638.54K	1.44%	-8.48K
Granahan SC Advantage	433.80K	0.98%	-20.00K
JNL Multi-Manager Small Cap Growth A	433.80K	0.98%	-20.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 13, 2024	Green James W	Chief Executive Officer	Buy	$29.10K
Jun 06, 2024	Green James W	Chief Executive Officer	Buy	$61.40K
Aug 17, 2023	Green James W	Chief Executive Officer	Buy	$109.50K
Mar 14, 2023	EDRICK ALAN I	-	Buy	$36.87K
Mar 15, 2023	EDRICK ALAN I	-	Buy	$42.42K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	2	-

HBIO Ownership FAQ

Who Owns Harvard Bioscience?

Harvard Bioscience shareholders are primarily institutional investors at 37.45%, followed by 10.30% insiders and 52.25% retail investors. The average institutional ownership in Harvard Bioscience's industry, Medical Instruments & Supplies Stocks, is 40.77%, which Harvard Bioscience falls below.

Who owns the most shares of Harvard Bioscience?

Harvard Bioscience’s largest shareholders are Amh equity (4.05M shares, 9.14%), Blackrock (2.84M shares, 6.55%), and Harvey partners (2.05M shares, 4.63%). Together, they hold 20.32% of Harvard Bioscience’s total shares outstanding.

Does Blackrock own Harvard Bioscience?

Yes, BlackRock owns 6.55% of Harvard Bioscience, totaling 2.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.1M$. In the last quarter, BlackRock increased its holdings by 9.99K shares, a 0.35% change.

Who is Harvard Bioscience’s biggest shareholder by percentage of total assets invested?

Amh equity is Harvard Bioscience’s biggest shareholder by percentage of total assets invested, with 2.21% of its assets in 4.05M Harvard Bioscience shares, valued at 1.77M$.

Who is the top mutual fund holder of Harvard Bioscience shares?

Harvey Partners Small-Cap Opportunity is the top mutual fund holder of Harvard Bioscience shares, with 4.42% of its total shares outstanding invested in 1.97M Harvard Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools